日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant African swine fever virus Uncharacterized protein K205R (War-58) CSB-YP315331AEI
CSB-EP315331AEI
CSB-BP315331AEI
CSB-MP315331AEI
CSB-EP315331AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Protein E248R (Ken-144), partial CSB-YP315332AEB1
CSB-EP315332AEB1
CSB-BP315332AEB1
CSB-MP315332AEB1
CSB-EP315332AEB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein M1249L (Pret-072), partial CSB-YP315333AYG
CSB-EP315333AYG
CSB-BP315333AYG
CSB-MP315333AYG
CSB-EP315333AYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein B263R (Pret-098) CSB-YP315334AYG
CSB-EP315334AYG
CSB-BP315334AYG
CSB-MP315334AYG
CSB-EP315334AYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein E301R (Pret-140) CSB-YP315335AYG
CSB-EP315335AYG
CSB-BP315335AYG
CSB-MP315335AYG
CSB-EP315335AYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein F317L (Mal-049) CSB-YP315336AYE
CSB-EP315336AYE
CSB-BP315336AYE
CSB-MP315336AYE
CSB-EP315336AYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein D345L (Pret-121) CSB-YP315337AYG
CSB-EP315337AYG
CSB-BP315337AYG
CSB-MP315337AYG
CSB-EP315337AYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Zinc finger protein B385R (War-090) CSB-YP315338AEI
CSB-EP315338AEI
CSB-BP315338AEI
CSB-MP315338AEI
CSB-EP315338AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein M448R (Mal-069) CSB-YP315339AYE
CSB-EP315339AYE
CSB-BP315339AYE
CSB-MP315339AYE
CSB-EP315339AYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein B475L (War-087), partial CSB-YP315340AEI
CSB-EP315340AEI
CSB-BP315340AEI
CSB-MP315340AEI
CSB-EP315340AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized membrane protein X69R (Ken-026), partial CSB-YP315341AEB
CSB-EP315341AEB
CSB-BP315341AEB
CSB-MP315341AEB
CSB-EP315341AEB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein D79L (War-114) CSB-YP315342AEI
CSB-EP315342AEI
CSB-BP315342AEI
CSB-MP315342AEI
CSB-EP315342AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Transmembrane protein EP84R (Mal-062), partial CSB-YP315343AYE1
CSB-EP315343AYE1
CSB-BP315343AYE1
CSB-MP315343AYE1
CSB-EP315343AYE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Transmembrane protein B66L (Mal-095), partial CSB-YP315344AYE
CSB-EP315344AYE
CSB-BP315344AYE
CSB-MP315344AYE
CSB-EP315344AYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein DP238L (Ken-158) CSB-YP315345AEB
CSB-EP315345AEB
CSB-BP315345AEB
CSB-MP315345AEB
CSB-EP315345AEB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Protein H339R (Pret-128) CSB-YP315346AYG
CSB-EP315346AYG
CSB-BP315346AYG
CSB-MP315346AYG
CSB-EP315346AYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caretta caretta Defensin-like turtle egg white protein TEWP CSB-YP315347CDU
CSB-EP315347CDU
CSB-BP315347CDU
CSB-MP315347CDU
CSB-EP315347CDU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Viral interleukin-10 homolog (BCRF1) CSB-YP315348EFC
CSB-EP315348EFC
CSB-BP315348EFC
CSB-MP315348EFC
CSB-EP315348EFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus quercinus Alpha-conotoxin-like Qc1.4a CSB-YP315349CXE
CSB-EP315349CXE
CSB-BP315349CXE
CSB-MP315349CXE
CSB-EP315349CXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative TLX1 neighbor protein (TLX1NB) CSB-YP315350HU
CSB-EP315350HU
CSB-BP315350HU
CSB-MP315350HU
CSB-EP315350HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×